Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Portola Pharmaceuticals Signs $150 Million Royalty Agreement with HealthCare Royalty Partners for Development and Commercialization of Andexanet Alfa
Monday, February 06, 2017Portola Pharmaceuticals Inc PTLA today announced that it has signed a million royalty agreement with HealthCare Royalty Partners HCR Under the terms of the agreement Portola received million at closing and may receive an additional million upon US...
FDA Accepts Two sBLAs for Merck’s KEYTRUDA® (pembrolizumab) for Locally Advanced or Metastatic Urothelial Cancer in Cisplatin-Ineligible First-Line and Second-Line Post-Platinum Failure Trea
Monday, February 06, 2017Merck NYSEMRK known as MSD outside the United States and Canada today announced that the US Food and Drug Administration FDA has accepted for review two supplemental Biologics License Applications sBLAs for KEYTRUDA pembrolizumab the companys antiPD...
Teva Confirms Generic Victoza® Patent Challenge in the United States
Friday, February 03, 2017Teva Pharmaceutical Industries Ltd announced that it has filed an abbreviated new drug application ANDA with the US Food and Drug Administration FDA seeking approval to market the generic version of Novo Nordisks Victoza liraglutide injection in the...
Lysogene Receives Orphan Drug Designation from FDA for LYS-GM101
Friday, February 03, 2017Lysogene a leading clinicalstage biotechnology company specializing in gene therapy for rare central nervous system diseases today announced that the US Food and Drug Administration FDA has granted orphan drug designation to LYSGM the companys gene t...
Cocoon Biotech Announces Partnership with Camargo Pharmaceutical Services for Development Programs
Friday, February 03, 2017Cocoon Biotech Inc is a biotechnology company focused on utilizing its silk proteinbased drug delivery technology for the development of formulations to treat osteoarthritis and other conditions for which many patients find existing treatments to be...
Hope Biosciences Acquires Worldwide Rights to Novel MERTK/AXL Inhibitor from NeoPharm
Thursday, February 02, 2017HOPE BIOSCIENCES INC announced that it has acquired exclusive and worldwide rights to develop and commercialize HOPE a unique MERTKAXLpancMET tyrosine kinase inhibitor through a licensing agreement with NeoPharm Co Ltd a South Korean pharmaceutical...
Meridian Lab and Apobiologix Enter into a Definitive Agreement for Docetaxel Injection
Thursday, February 02, 2017Meridian Laboratories Inc a Buffalo IL based specialtyoncology drug development company announced today that it has entered into a definitive agreement with Apobiologix a part of the Apotex Inc group to develop and market a onevial liquid improved fo...
Allergan Successfully Completes LifeCell Acquisition
Thursday, February 02, 2017Allergan plc a leading global biopharmaceutical company announced that it has successfully completed the acquisition of LifeCell Corporation a leading regenerative medicine company Allergan acquired LifeCell for approximately billion in cash The Co...
GenSight Biologics Receives FDA Orphan Drug Designation for GS030
Wednesday, February 01, 2017GenSight Biologics a biopharma company that discovers and develops innovative gene therapies for neurodegenerative retinal diseases and diseases of the central nervous system today announced that the US Food and Drug Administration FDA has granted or...
Ipsen to acquire Primary Care platform in Italy from Akkadeas Pharma
Wednesday, February 01, 2017Ipsen announces that it has signed an agreement to take an equity stake in Akkadeas Pharma with an option to take control of the company in the future Akkadeas Pharma is a privatelyheld consumer health care company in Italy with a diversified gastroi...
